Regulatory Approval/Market LaunchEckert & Ziegler Gains Approval for GalliaPharm® in Japan 19.09.2025 / 12:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Berlin, 19 ...

The surgical imaging market represents a revolutionary segment within the healthcare technology landscape, encompassing ...

The vascular access device market is experiencing a steady growth rate with a CAGR of ~6% during the forecast period. The primary factor driving the market growth is the increasing incidence of ...

Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, has become aware of a ...

The biopreservation market is anticipated to grow at a CAGR of 15% during the forecast period. This growth is largely driven ...

The Orthopedic Implants Market sits at the intersection of demographic inevitability and relentless innovation. As ...

The promise of messenger RNA (mRNA) has moved far beyond its pandemic-era spotlight. In oncology, mRNA has emerged as a ...

Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that patient recruitment is complete ...

The global Vision Impairment Devices Market is expected to grow at a rate of 8% to reach $5.5 billion by 2026. Increasing ...

The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period. This ...

The 3D printing medical devices market is expected to grow at a CAGR of ~17% during the forecast period. The market is ...

The clinical data management systems market is expected to grow at a robust CAGR of 12% from 2025 to 2030. This growth is ...